SNY logo

SNY
Sanofi-Aventis

5,669
Mkt Cap
$117.45B
Volume
1.7M
52W High
$60.12
52W Low
$44.62
PE Ratio
12.00
SNY Fundamentals
Price
$48.90
Prev Close
$48.26
Open
$48.63
50D MA
$49.93
Beta
0.28
Avg. Volume
2.22M
EPS (Annual)
$2.40
P/B
1.43
Rev/Employee
$525,340.04
Loading...
Loading...
News
all
press releases
TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia
Teva files an NDA seeking FDA approval for its once-monthly olanzapine LAI for the treatment of adults with schizophrenia.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Zacks·2d ago
News Placeholder
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Zacks·2d ago
News Placeholder
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Zacks·2d ago
News Placeholder
KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study
Kymera jumps after phase Ib study data show KT-621 delivers strong STAT6 degradation and broad clinical activity in patients with atopic dermatitis.
Zacks·2d ago
News Placeholder
KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study
Kymera jumps after phase Ib study data show KT-621 delivers strong STAT6 degradation and broad clinical activity in patients with atopic dermatitis.
Zacks·2d ago
News Placeholder
Sanofi $SNY Shares Sold by London & Capital Asset Management Ltd
London & Capital Asset Management Ltd lessened its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 69.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Sanofi $SNY Shares Sold by London & Capital Asset Management Ltd
London & Capital Asset Management Ltd lessened its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 69.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Sanofi $SNY Holdings Boosted by First Trust Advisors LP
First Trust Advisors LP raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 14.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange...
MarketBeat·2d ago
News Placeholder
Sanofi $SNY Holdings Boosted by First Trust Advisors LP
First Trust Advisors LP raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 14.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange...
MarketBeat·2d ago

Latest SNY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.